c-Myc inhibitor 4

• UNSPSC Description:

  c-Myc inhibitor 4 is a potent, orally bioavailable c-MYC-reducing compound.

• Target Antigen:

  c-Myc

• Type:

  Reference compound

• Related Pathways:

  Apoptosis

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/c-myc-inhibitor-4.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC(OC)=C2N(C[C@@H]3CNCCO3)C(C4=CC=C(N5[C@@H](C)CC[C@@H]5C)N=C4)=NC2=C1F)NC

• Molecular Weight:

  496.58

• References & Citations:

  [1]Medina JR, et al. Cell-Based Drug Discovery: Identification and Optimization of Small Molecules that Reduce c-MYC Protein Levels in Cells. J Med Chem. 2021 Nov 11;64(21):16056-16087.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2763366-92-1